- Home
- PED vs RFL Comparison
PED vs RFL Comparison
Compare PED & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | PED | RFL |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Real Estate |
| Sector | Energy | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 61.1M |
| IPO Year | 2012 | 2017 |
Fundamental Metrics
Financial Performance| Metric | PED | RFL |
|---|---|---|
| Price | $0.58 | $1.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 373.0K | 85.8K |
| Earning Date | 01-01-0001 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.28 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $39,553,000.00 | $917,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $305.89 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 28.49 | ★ 43.96 |
| 52 Week Low | $0.43 | $1.12 |
| 52 Week High | $0.82 | $3.19 |
Technical Indicators
Market Signals| Indicator | PED | RFL |
|---|---|---|
| Relative Strength Index (RSI) | 45.71 | 72.75 |
| Support Level | $0.57 | $1.41 |
| Resistance Level | $0.60 | $1.60 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 5.46 | 70.92 |
Price Performance
Historical ComparisonAbout PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.